The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Dr. Michael J. Galvin, In the Matter of
20260358: ACP Vault, LP; US Fertility Holdings, LLC
20260360: WP Deluxe Apexco LP; Matthews International Corporation
20260361: US Fertility Holdings, LLC; ACP Vault, LP
20260367: Kenneth B. Dart; Flutter Entertainment plc
20260391: LongRange Capital Fund I, L.P.; All Day Holdings LLC
20260445: Republic Services, Inc.; Quikrete Holdings, Inc
20260456: The Charles Schwab Corporation; Forge Global Holdings, Inc.
20260458: MCR Hospitality Fund IV LP; Soho House & Co Inc.
20260479: Investindustrial VIII S.C.Sp.; TreeHouse Foods, Inc.
20260489: Nautic Partners XI-A, L.P.; Senderra RX Parent, LLC
20260497: Windjammer Capital Fund VI, L.P.; Platte River Equity III, L.P.
20260507: Clayton, Dubilier & Rice Fund XII, L.P.; Sealed Air Corporation
20260523: Airbus SE; Platinum Equity Small Cap Fund, L.P.
20260358: ACP Vault, LP; US Fertility Holdings, LLC
Philip Serpe, In the Matter of
Rytr LLC, In the Matter of
According to the FTC’s complaint, Rytr’s service generated detailed reviews that contained specific, often material details that had no relation to the user’s input, and these reviews almost certainly would be false for the users who copied them and published them online. In many cases, subscribers’ AI-generated reviews featured information that would deceive potential consumers who were using the reviews to make purchasing decisions. The complaint further alleges that at least some of Rytr’s subscribers used the service to produce hundreds, and in some cases tens of thousands, of reviews potentially containing false information.
The proposed order settling the Commission’s complaint is designed to prevent Rytr from engaging in similar illegal conduct in the future. It would bar the company from advertising, promoting, marketing, or selling any service dedicated to – or promoted as – generating consumer reviews or testimonials.
On December 22, 2025, the FTC issued an order to reopen and set aside a 2024 final consent order involving Rytr LLC.